Journal of Urgent Care Medicine

Some Glucose Monitor Sensors Could Be Inaccurate; What To Do

Recently, Abbott Diabetes Care posted an alert for a subset of its FreeStyle Libre 3 and Libre 3 Plus continuous glucose monitor (CGM) sensors. Internal testing revealed that some sensors manufactured on a single production line may provide inaccurate, low glucose readings—potentially leading patients to delay or skip necessary insulin doses. The alert affects approximately 3 million sensors in the United States; about half are estimated to have expired or already been used. Globally, Abbott …

Patients Can Miss Critical Glucose Monitor Alerts, FDA Warns

The Food and Drug Administration (FDA) posted an alert this month warning that patients who use continuous glucose monitors (CGMs), insulin pumps, automated insulin dosing systems, and other diabetes devices are at risk of not receiving or not hearing audible alerts from their smartphones regarding their devices. A missed alert could possibly lead to severe hypoglycemia, severe hyperglycemia, diabetic ketoacidosis, and death, the agency says. Because apps for diabetes CGMs and other devices allow users …

Login to JUCM